Louisa Collins
QIMR Berghofer Medical Research Institute, QLD, Australia
- This delegate is presenting an abstract at this event.

I am a health economist, Senior Research Fellow and Group Lead of Health Economics at QIMR Berghofer Medical Research Institute in Brisbane, Australia. I have 20 years research experience performing economic evaluations, decision-analytic modelling and health technology assessments. I hold a PhD and MPH in Public Health from Queensland University of Technology (QUT) and Bachelor of Economics from University of New England, NSW. My research is devoted to cancer economics and I currently work in the areas of cancer prevention, supportive care interventions for cancer survivors, and the financial burden of cancer on families. I also sit on the Medical Services Advisory Committee, which assesses new technologies and services for reimbursement by the Commonwealth Department of Health.
Presentations this author is a contributor to:
Estimating the magnitude and healthcare costs of melanoma in situ and thin invasive melanoma overdiagnosis in Australia. (#85)
11:50 AM
Daniel Lindsay
Session 10.1 - Epidemiology, Burden, Risk
Shave biopsy - a “compromise” technique? Factors influencing the use of shave biopsy for thin melanoma diagnosis. (#230)
2:06 PM
Daniel Lindsay
Session 15.3 - AI and Technology
Cost-effectiveness analysis and return on investment of SunSmart Western Australia to prevent skin cancer (#82)
11:20 AM
Carolyn Minto
Session 10.1 - Epidemiology, Burden, Risk
The SUNEX model: Health and financial burden of the harms and benefits of ultraviolet radiation in Australia and New Zealand. (#46)
12:00 PM
Thomas M Elliott
Session 6.2 - New Technologies for Prevention & Detection
Exploring the Impact of adhering to the new Position Statement on Balancing the Harms and Benefits of Sun Exposure. (#96)
11:36 AM
Thomas M Elliott
Session 10.3 - Settings & Policy 3: Government